Fennec Pharmaceuticals (FENC) Earnings Date and Reports 2024

2 days ago  · Fennec Pharmaceuticals released Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.20, which missed analysts' consensus estimates of $0.06 by $0.26. Quarterly revenue was reported to be $7.26 million , below the consensus estimate of $13.67 million .


Install CouponFollow Chrome Extension   CouponFollow Extension

$0.20
OFF

Fennec Pharmaceuticals (FENC) Earnings Date And Reports 2024

1 week from now

2 days ago  · Fennec Pharmaceuticals released Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.20, which missed analysts' consensus estimates of $0.06 by $0.26. Quarterly revenue was reported to be $7.26 million , below the consensus estimate of $13.67 million .

marketbeat.com

$5
OFF

Fennec Pharmaceuticals Reports Third Quarter 2024 Financial …

1 week from now

Sep 30, 2024  · Net Earnings – Net loss for the quarter ended September 30, 2024 was $5.7 million (basic and diluted loss of $0.21 per share) compared to a net loss of $1.9 million (basic …

fennecpharma.com

$0.05
OFF

Fennec Pharmaceuticals (FENC) Earnings Date & Reports - TipRanks

1 week from now

Fennec Pharmaceuticals (FENC) will release its next earnings report on Aug 9, 2024. In the last quarter Fennec Pharmaceuticals reported -$0.058 EPS in relation to $0.41 expected by the …

tipranks.com

$0.21
OFF

Fennec Pharmaceuticals Inc. (FENC) Stock Earnings Dates & Report

1 week from now

3 days ago  · Fennec Pharmaceuticals GAAP EPS of -$0.21 misses by $0.12, revenue of $6.97M misses by $2.01M SA News Thu, Nov. 07 1 Comment Earnings history by period FQ2 2024 …

seekingalpha.com

$5
OFF

Fennec Pharmaceuticals Reports Third Quarter 2024 ... - Morningstar

1 week from now

Nov 7, 2024  · Net Earnings – Net loss for the quarter ended September 30, 2024 was $5.7 million (basic and diluted loss of $0.21 per share) compared to a net loss of $1.9 million (basic and …

morningstar.com

$7
OFF

Fennec Pharmaceuticals Reports Q3 2024 Financial Results

1 week from now

Nov 9, 2024  · In its latest earnings report, Fennec Pharmaceuticals reported net product sales of $7.0 million for the third quarter of 2024, highlighting increased momentum in the adolescent …

businessinsider.com

76%
OFF

Fennec Pharmaceuticals Earnings Dates, Reports, Calls 2014-2024 …

1 week from now

On FENC's earnings call on Invalid Date, . Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 2024 earnings per share (EPS) of -$0.20, up 4.76% year over year. Total FENC earnings …

wallstreetzen.com

$7
OFF

Fennec Pharmaceuticals Inc (FENC) Q3 2024 Earnings Call …

1 week from now

Nov 9, 2024  · Fennec Pharmaceuticals Inc (NASDAQ:FENC) reported net product sales of $7.0 million for the third quarter of 2024, an increase from $6.5 million in the same quarter of 2023.

yahoo.com

$0.27
OFF

Fennec Pharmaceuticals (FRX) Earnings Date And Reports 2024

1 week from now

Fennec Pharmaceuticals issued Q2 2024 earnings on August 13, 2024, reporting an EPS of -C$0.27, which missed analysts' consensus estimates of C$0.08 by C$0.35. Quarterly revenue …

marketbeat.com

$5
OFF

Fennec Pharmaceuticals Reports Second Quarter 2024 Financial …

1 week from now

Aug 13, 2024  · Net Earnings – Net loss for the quarter ended June 30, 2024 was $5.6 million (basic and diluted loss of $0.20 per share) compared to a net loss of $5.4 million (basic and …

morningstar.com

$0.20
OFF

ACADIA Pharmaceuticals (ACAD) Earnings Date And Reports 2024

1 week from now

2 days ago  · ACADIA Pharmaceuticals announced Q3 2024 earnings on November 6, 2024, reporting an EPS of $0.20, which beat analysts' consensus estimates of $0.14 by $0.06. …

marketbeat.com

$0.96
OFF

Crinetics Pharmaceuticals (CRNX) Earnings Date And Reports 2024

1 week from now

2 days ago  · Crinetics Pharmaceuticals posted Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.96, which missed analysts' consensus estimates of -$0.91 by $0.05. …

marketbeat.com

$220
OFF

Ligand Pharmaceuticals Inc (LGND) Q3 2024 Earnings Call …

1 week from now

Nov 8, 2024  · Cash and Short-term Investments: $220 million as of September 30, 2024. 2024 Revenue Guidance: Raised to $160 to $165 million. 2024 Adjusted EPS Guidance: $5.55 to …

yahoo.com

$1.34
OFF

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial …

1 week from now

Nov 8, 2024  · On a non-GAAP basis, the Company reported diluted earnings per share of $1.34 for the third quarter of 2024 compared to $1.27 in the prior year period. The Company reported …

anipharmaceuticals.com

$0.88
OFF

Tarsus Pharmaceuticals (TARS) Earnings Date And Reports 2024

1 week from now

Tarsus Pharmaceuticals issued Q2 2024 earnings on August 8, 2024, reporting an EPS of -$0.88, which beat analysts' consensus estimates of -$0.98 by $0.10. Quarterly revenue was reported …

marketbeat.com

$0.60
OFF

Marinus Pharmaceuticals (MRNS) Earnings Date And Reports 2024

1 week from now

Marinus Pharmaceuticals issued Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.60, which missed analysts' consensus estimates of -$0.59 by $0.01. Quarterly revenue was …

marketbeat.com

FAQs about Fennec Pharmaceuticals (FENC) Earnings Date and Reports 2024 Coupon?

What did fennec pharmaceuticals (Fenc) earn in Q3 2024?

Fennec Pharmaceuticals Inc (FENC) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... Net Product Sales: $7.0 million for Q3 2024, compared to $6.5 million in Q3 2023. Year-to-Date Net Product Sales: Approximately $22 million for the first nine months of 2024. ...

What time does fennec pharmaceuticals (Fenc) hold a conference call?

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Robert Andrade - CFO Jeffrey Hackman - CEO and Board Member Conference Call ... ...

Should I buy Fennec Pharmaceuticals (Fenc) stock?

According to 5 Wall Street research analysts, investors should 'buy' Fennec Pharmaceuticals (Fenc) stock. There are currently 5 buy ratings for the stock, and it is the consensus among analysts. ...

What happened to fennec pharmaceuticals?

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company reported a US$17m loss in the full financial year, compared to the latest trailing-twelve-month loss of US$17m. ...

How much money does fennec Pharmaceuticals make a year?

Fennec Pharmaceuticals (NASDAQ:FENC) generates $-23,710,000.00 in net income (profit) each year. ...

What is the target price for fennec pharmaceuticals?

Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on Fennec Pharmaceuticals and set a price target of $18.00. The company's shares closed last Monday at $8.22. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension